We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-23.25%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$358M
AUM Growth
-$182M
Cap. Flow
-$93.9M
Cap. Flow %
-26.23%
Top 10 Hldgs %
31.98%
Holding
756
New
76
Increased
136
Reduced
196
Closed
54

Sector Composition

Rank Sector Weight
1 Healthcare 11.28%
2 Technology 9.96%
3 Financials 8.31%
4 Consumer Discretionary 6.97%
5 Communication Services 4.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HYG icon
326
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$68.4K 0.02%
+580
New +$49K
COO icon
327
Cooper Companies
COO
$13.8B
$67.5K 0.02%
980
-136
-12% -$11.1K
ILMN icon
328
Illumina
ILMN
$28.8B
$67.5K 0.02%
254
-52
-17% -$14.5K
ZIV
329
DELISTED
VelocityShares Daily Inverse VIX Medium Term ETN
ZIV
$66.2K 0.02%
+2,000
New +$126K
HIG icon
330
Hartford Financial Services
HIG
$38.5B
$65.9K 0.02%
1,870
ISRG icon
331
Intuitive Surgical
ISRG
$128B
$65.4K 0.02%
396
-96
-20% -$17.6K
D icon
332
Dominion Energy
D
$61.9B
$64.3K 0.02%
891
-2,318
-72% -$189K
ADSK icon
333
Autodesk
ADSK
$47.7B
$63.4K 0.02%
406
GTHX
334
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$63.2K 0.02%
+5,738
New +$107K
ALL icon
335
Allstate
ALL
$67.3B
$63K 0.02%
687
SYK icon
336
Stryker
SYK
$129B
$62.9K 0.02%
378
-84
-18% -$16.4K
SRPT icon
337
Sarepta Therapeutics
SRPT
$1.73B
$62.2K 0.02%
636
-1,387
-69% -$159K
BMRN icon
338
BioMarin Pharmaceuticals
BMRN
$11.8B
$61.5K 0.02%
728
-165
-18% -$14.2K
PCG icon
339
PG&E
PCG
$47B
$61.2K 0.02%
6,807
META icon
340
PUT
Meta Platforms (Facebook)
META
$1.51T
$60K 0.02%
+40
New +$7.83K
ACHC icon
341
Acadia Healthcare
ACHC
$2.98B
$60K 0.02%
+3,268
New +$93.6K
ANSS
342
DELISTED
Ansys
ANSS
$58.1K 0.02%
250
JNPR
343
DELISTED
Juniper Networks
JNPR
$58K 0.02%
3,028
-141,941
-98% -$3.19M
NTES icon
344
NetEase
NTES
$79.3B
$57.8K 0.02%
900
+415
+86% +$27.3K
TXT icon
345
Textron
TXT
$16.8B
$56.6K 0.02%
2,123
EWW icon
346
iShares MSCI Mexico ETF
EWW
$1.91B
$51.8K 0.01%
1,828
-2,309
-56% -$96.3K
INFY icon
347
Infosys
INFY
$47.1B
$51.2K 0.01%
6,234
DBVT
348
DBV Technologies
DBVT
$822M
$51K 0.01%
+1,300
New +$117K
NKTR icon
349
Nektar Therapeutics
NKTR
$2.38B
$50.8K 0.01%
190
-750
-80% -$232K
CRON
350
Cronos Group
CRON
$1.06B
$50.6K 0.01%
8,925
-5,400
-38% -$35.9K

Similar funds

Exane Derivatives's Q1 2020 Portfolio in Review

As of Q1 2020, Exane Derivatives held 756 positions worth $358M, down 34% from $540M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Exane Derivatives withdrew a net $93.9M in Q1 2020, closing 54 positions and reducing 196 holdings. Its most notable exit was Ferrari, an estimated $13.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 5.9% a quarter earlier, followed by Technology and Financials.

Against the trend, Exane Derivatives opened a new position in VanEck Oil Services ETF worth $2.8M.

  • Exane Derivatives's largest Q1 2020 buy was VanEck Oil Services ETF: 34,775 shares worth $2.8M.
  • Exane Derivatives added most to iShares MSCI Poland ETF in Q1 2020, an estimated $9.75M increase.
  • Exane Derivatives's biggest Q1 2020 reduction was UBS Group, cutting an estimated $24.1M.
  • Exane Derivatives fully exited Ferrari in Q1 2020, selling an estimated $13.3M.
  • Exane Derivatives's ten largest holdings make up 32% of its $358M portfolio in Q1 2020.
  • Exane Derivatives opened 76 new positions and closed 54 in Q1 2020.
  • Exane Derivatives's portfolio value fell 34% quarter-over-quarter to $358M.

Based on Exane Derivatives's 13F filing for Q1 2020, filed 17 Apr 2020.